Sign in
Active, not recruitingNo phase

Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care

Key facts

Who runs it
University of Turku
Where
Finland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
10,000 people enrolled
Started
1 Sept 2023
Expected to end
31 Dec 2028
Type of study
Observational
Record updated
24 February 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Two sodium measurements in Tyks laboratories between 12-36 hours

Who cannot take part

  • -

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Study Objectives and Hypothesis

Read full original descriptionShow less

To determine the incidence of hyponatremia at TYKS and the factors associated with it.

To assess how rapidly hyponatremia was corrected and how the rate of correction affected patient prognosis.

To evaluate treatment modalities and their impact on patient prognosis, length of hospital stay, and their appropriateness in comparison with national and international treatment guidelines.

To determine the incidence of osmotic demyelination at TYKS and the factors associated with it.

To assess other complications and their clinical significance.

To evaluate the impact of hyponatremia on various endpoints, such as mortality, length of hospital stay, seizures, confusion, and similar outcomes.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Significance of Hyponatremia
Record updated
24 February 2026